40 pages. "The majority of the changes proposed in the Advance Notice were the result of continuing implementation of the provisions of the [ACA], as well as continuing steps towards CMS' efforts to provide [Medicare Advantage and Prescription Drug] enrollees with higher quality of care, more transparency and more information, and to continue moving towards quality based payments for both plan sponsors and providers. Most of the items proposed in the Advance Notice were adopted and finalized without modification in the Final Notice. Many of the changes for 2016, such as calculation/rebasing of the county Benchmarks, revisions to benefit parameters, and updates to risk score calculation components, will affect nearly all Medicare Advantage and Prescription Drug Plans. This document presents a summary of key changes for 2016 as adopted in the Final Notice."